Skip to main content
Funded Studies

Gilles Tamagnan, PhD

Vice President of Chemistry and Translational Research at Molecular NeuroImaging

Laboratory Research and Development Director at Institute for Neurodegenerative Disorders

Location: New Haven, CT United States

Gilles D. Tamagnan, PhD, received his doctorate in medicinal chemistry at the University Joseph Fourier in Grenoble, France in 1993. After a postdoctoral fellowship spent on the crystallization of protein, Dr. Tamagnan completed a second postdoctoral fellowship at RBI in Boston, Massachusetts. His research subject was to develop new ligands for the diagnosis of Parkinson’s disease using compounds labeled with radioactive atoms, and Dr. Tamagnan is a co-inventor of DatScan.

He joined the Neuroimaging Program at Yale University in June 1997 to work on the development of new radioligands to study neurodegenerative diseases and went to the Institute for Neurodegenerative Disorders (IND) in 2003. Dr. Tamagnan has been the recipient of numerous grants and is the co-inventor of ligands used for the diagnosis of Parkinson’s. He joined IND as laboratory research and development director in 2003.

Associated Grants

  • Development of an MgluR4 PET Radioligand


  • Development of Functional Imaging for CB-1 and 5-HT1a in PD Participants with Dyskinesia


  • Development of an mGluR5 Imaging Marker for Parkinson's Disease


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.